Ocular myasthenia and nitrofurantoin

American Journal of Ophthalmology

Volumn 130, Issue 4, 2000, Pages 531-533

  Wasserman, Barry N ^a   Chronister, Ted E ^b   Stark, Bruce I ^a   Saran, Bruce R ^a  

^a Chester County Eye Care Associates   (United States)

^b NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITROFURANTOIN;

ARTICLE; CASE REPORT; CLINICAL FEATURE; DIPLOPIA; DRUG EFFECT; DRUG RESPONSE; EYE DISEASE; FEMALE; HUMAN; MYASTHENIA; PRIORITY JOURNAL; PTOSIS; SCHOOL CHILD; SYMPTOM; TREATMENT OUTCOME; URINARY TRACT SURGERY;

EID: 0033808274     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(00)00556-0     Document Type: Article

References (5)

1. Wittbrodt E.T. Drugs and myasthenia gravis. Arch Int Med. 157:1997;399-408.
2. Uyama E., Fujiki N., Uchino M. Exacerbation of myasthenia gravis during interferon-a treatment. J Neurol Sci. 144:1996;221-222.
3. Bora I., Karh N., Bakar M., et al. Myasthenia gravis following IFN-a-2a treatment. Eur Neurol. 38:1997;68.
4. Roquer J., Cano A., Seoane J.L., Pou Serradell A. Myasthenia gravis and ciprofloxacin. Acta Neurol Scand. 94:1996;419-420.
5. Pijpers E., van Rijswijk R.E.N., Takx-Kohlen B., Schrey G. A clarithromycin-induced myasthenic syndrome. Clin Infec Dis. 22:1996;175-176.